HSAQ vs. TCMD, LUNG, SKIN, INO, OBIO, ANGO, UTMD, RCEL, TLSI, and DCTH
Should you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include Tactile Systems Technology (TCMD), Pulmonx (LUNG), Beauty Health (SKIN), Inovio Pharmaceuticals (INO), Orchestra BioMed (OBIO), AngioDynamics (ANGO), Utah Medical Products (UTMD), AVITA Medical (RCEL), TriSalus Life Sciences (TLSI), and Delcath Systems (DCTH). These companies are all part of the "surgical & medical instruments" industry.
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.
Health Sciences Acquisitions Co. 2 has a beta of 0.09, indicating that its share price is 91% less volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.
Tactile Systems Technology has a consensus target price of $30.00, suggesting a potential upside of 135.66%. Given Tactile Systems Technology's higher possible upside, analysts clearly believe Tactile Systems Technology is more favorable than Health Sciences Acquisitions Co. 2.
Tactile Systems Technology received 361 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users.
89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Comparatively, 1.0% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Tactile Systems Technology has higher revenue and earnings than Health Sciences Acquisitions Co. 2.
In the previous week, Tactile Systems Technology had 2 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 2 mentions for Tactile Systems Technology and 0 mentions for Health Sciences Acquisitions Co. 2. Tactile Systems Technology's average media sentiment score of 1.10 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that Tactile Systems Technology is being referred to more favorably in the news media.
Tactile Systems Technology has a net margin of 10.19% compared to Health Sciences Acquisitions Co. 2's net margin of 0.00%. Tactile Systems Technology's return on equity of 15.88% beat Health Sciences Acquisitions Co. 2's return on equity.
Summary
Tactile Systems Technology beats Health Sciences Acquisitions Co. 2 on 11 of the 13 factors compared between the two stocks.
Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HSAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Health Sciences Acquisitions Co. 2 Competitors List
Related Companies and Tools
